PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.87%
Some net income increase while CFLT is negative at -21.27%. John Neff would see a short-term edge over the struggling competitor.
-85.57%
Negative yoy D&A while CFLT is 11.19%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
10.75%
SBC growth well above CFLT's 10.18%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-134.02%
Negative yoy working capital usage while CFLT is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-327.10%
Both yoy AR lines negative, with CFLT at -491.34%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-22.51%
Negative yoy inventory while CFLT is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
179.54%
Lower AP growth vs. CFLT's 520.41%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
117.34%
Growth well above CFLT's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-103.89%
Negative yoy while CFLT is 76.96%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-23.46%
Negative yoy CFO while CFLT is 167.71%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
1.38%
Lower CapEx growth vs. CFLT's 35.69%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
-31.92%
Both yoy lines negative, with CFLT at -14.99%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
4.07%
Below 50% of CFLT's 55.15%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-101.23%
Both yoy lines negative, with CFLT at -28.82%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-1289.41%
We reduce yoy invests while CFLT stands at 92.42%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
9.68%
Debt repayment growth of 9.68% while CFLT is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
1894.43%
Issuance growth of 1894.43% while CFLT is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.